XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Restricted Stock, Activity

Nine months ended September 30,

2022

2021

Shares

Weighted Average Grant-Date Fair Value

Shares

Weighted Average Grant-Date Fair Value

Unvested shares, January 1,

165,131

$

21.72

148,885

$

18.00

Granted

18,180

25.30

Vested

(37,748)

19.20

(39,449)

18.00

Forfeited

(1,212)

27.16

(17,777)

18.00

Unvested shares, September 30,

126,171

$

22.45

109,839

$

19.21

Schedule of Share-based Compensation, Stock Options, Activity

The Company’s stock option activity during the nine months ended September 30, 2022 and 2021 are summarized below (dollars in thousands, except per share data, unaudited):

Nine months ended September 30,

2022

2021

    

Shares

    

Weighted Average
Exercise Price

Weighted Average Remaining Contractual Term (in years)

    

Aggregate
Intrinsic
Value (1)

    

Shares

    

Weighted Average
Exercise Price

Weighted Average Remaining Contractual Term (in years)

    

Aggregate
Intrinsic
Value (1)

Outstanding at January 1,

415,870

$

24.15

$

1,338

495,489

$

23.67

$

1,340

Granted

$

$

$

$

Exercised

(5,600)

$

11.22

$

56

(7,480)

$

12.59

$

91

Forfeited/Expired

(32,381)

$

27.32

$

(39,719)

$

26.93

$

1

Outstanding at September 30,

377,889

$

24.07

5.13

$

470

448,290

$

23.57

5.92

$

1,302

Exercisable at September 30,

336,489

$

23.69

4.88

$

470

384,690

$

22.97

5.58

$

1,302

(1)The aggregate intrinsic value of stock option in the table above represents the total pre-tax intrinsic value (the amount by which the current market value of the underlying stock exceeds the exercise price of the option) that would have been received by the option holders had all option holders exercised their options on September 30, 2022. This amount changes based on changes in the market value of the Company's stock.